Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Preferred Shares: 2012

  • RedHill Biopharma's Preferred Shares was N/A to $8.0 million in Q4 2012 from the same period last year, while for Dec 2012 it was $8.0 million, marking a year-over-year change of. This contributed to the annual value of $8.0 million for FY2012, which is N/A change from last year.
  • Latest data reveals that RedHill Biopharma reported Preferred Shares of $8.0 million as of Q4 2012.
  • Over the past 5 years, RedHill Biopharma's Preferred Shares peaked at $8.0 million during Q4 2012, and registered a low of $8.0 million during Q4 2012.
  • For the 1-year period, RedHill Biopharma's Preferred Shares averaged around $8.0 million, with its median value being $8.0 million (2012).